GlucoMe

Company Overview

Snapshot

Founded in December 2013 by Yiftah Ben Aharon and Dov Moran, GlucoMe operated with 1–10 employees. The company was acquired by CuraLife in January 2021, ceasing operations.

Business overview

GlucoMe developed and marketed a comprehensive digital solution for diabetes management, leveraging an algorithm-based decision-support system. This system analyzed diabetes data to provide medical teams with treatment recommendations, forming an autonomous diabetes healthcare platform. The solution facilitated smart, cost-effective remote care and monitoring, streamlining diabetes management for patients, caregivers, and medical professionals. The platform integrated individual patient and population management, enabling organizations to scale while delivering quality care. GlucoMe's offerings included a wireless blood glucose monitor, a mobile app, a cloud-based Digital Diabetes Clinic, and a Control Tower for data-driven prioritization and management, operating within the.

Strategic signal

In June 2019, GlucoMe received CE Mark approval for its diabetes decision support technology. This regulatory milestone was critical for market expansion within Europe, validating the safety and efficacy of its digital diabetes management platform and signaling readiness for broader commercial adoption.

Company Intelligence Q&A

What is GlucoMe's primary focus?

GlucoMe focuses on developing a comprehensive digital solution for diabetes management, utilizing an algorithm-based decision-support system to analyze diabetes data and provide treatment recommendations.

When was GlucoMe founded and by whom?

GlucoMe was founded in December 2013 by Yiftah Ben Aharon and Dov Moran.

What was a significant regulatory achievement for GlucoMe?

In June 2019, GlucoMe obtained CE Mark approval for its diabetes decision support technology, enabling its use in European markets.

What was the outcome for GlucoMe?

GlucoMe was acquired by CuraLife in January 2021 and subsequently ceased to operate.

Did GlucoMe engage in any international partnerships?

In August 2018, Merck KGaA and GlucoMe partnered to pilot remote, digital diabetes care in Vietnam. Additionally, in April 2018, GlucoMe and DiaMan announced the market launch of GlucoMe's digital diabetes care solution in Central America.